Gene
PPARGC1A
PPARG coactivator 1 alpha
Explore in graph →CI-GENE-00020500HGNC:9237 ENSG00000109819 NCBI 10891 Approved
Curated evidence
Clinical evidence (2)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 28978917
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| PPARGC1A Fusion2 | ||||||||
| (functional) | —UNRESOLVED | Functional | D | Supports Gain Of Function | 3 | submitted | EID11157Figure 3. NIH3T3 cells stably transduced with lentiviral expression vector for EGFR, PPARGC1A or EGFR (exon 16)::PPARGC1A (exon2) fusion, or control were implanted into nude mice. Control and PPARGC1A… (full text at CIViC) PMID 28978917 · Egashira et al., 2017 · Open in CIViC | civic |
| (diagnostic) | Skin Squamous Cell Carcinoma | Diagnostic | D | Supports Positive | 2 | submitted | EID10997By transcriptome sequencing, they identified the fusion variant EGFR::PPARGC1A in around 30% (31 out of 102) of cutaneous squamous cell carcinoma (cSCC). They found that the lesions harboring the fusi… (full text at CIViC) PMID 28978917 · Egashira et al., 2017 · | |
Cohorts
Alteration frequency by cohort (0)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
Data not yet available
Literature
Linked publications (0)
Data not yet available